PNC Financial Services Group’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Buy
5,585
+13
+0.2% +$240 ﹤0.01% 2685
2025
Q4
$76.5K Sell
5,572
-15
-0.3% -$234 ﹤0.01% 2980
2025
Q3
$98.9K Hold
5,587
﹤0.01% 2815
2025
Q2
$84.3K Buy
5,587
+15
+0.3% +$249 ﹤0.01% 2821
2025
Q1
$89.7K Buy
+5,572
New +$104K ﹤0.01% 2736
2024
Q4
Sell
-9,894
Closed -$174K 4895
2024
Q3
$174K Sell
9,894
-9,895
-50% -$169K ﹤0.01% 2300
2024
Q2
$221K Hold
19,789
﹤0.01% 2069
2024
Q1
$172K Hold
19,789
﹤0.01% 2280
2023
Q4
$242K Buy
+19,789
New +$137K ﹤0.01% 2024
2022
Q1
Sell
-34
Closed -$1K 4661
2021
Q4
$1K Hold
34
﹤0.01% 4312
2021
Q3
$1K Hold
34
﹤0.01% 4215
2021
Q2
$1K Hold
34
﹤0.01% 4131
2021
Q1
$1K Hold
34
﹤0.01% 4047
2020
Q4
$1K Hold
34
﹤0.01% 3915
2020
Q3
$0 Hold
34
﹤0.01% 4015
2020
Q2
$0 Buy
+34
New +$306 ﹤0.01% 4019
2019
Q4
Sell
-300
Closed -$5K 4074
2019
Q3
$5K Hold
300
﹤0.01% 3741
2019
Q2
$4K Hold
300
﹤0.01% 3785
2019
Q1
$5K Hold
300
﹤0.01% 3743
2018
Q4
$3K Hold
300
﹤0.01% 3807
2018
Q3
$4K Hold
300
﹤0.01% 3865
2018
Q2
$5K Hold
300
﹤0.01% 3840
2018
Q1
$4K Hold
300
﹤0.01% 3932
2017
Q4
$7K Hold
300
﹤0.01% 3794
2017
Q3
$6K Hold
300
﹤0.01% 3823
2017
Q2
$10K Hold
300
﹤0.01% 3583
2017
Q1
$6K Buy
+300
New +$4.08K ﹤0.01% 3682

Other funds holding PLSE

PNC Financial Services Group's PLSE Position: Q1 2026 in Review

PNC Financial Services Group increased its Pulse Biosciences (PLSE) stake by 0.23% in Q1 2026, buying an estimated $240 and bringing the position to 5,585 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2685.

PNC Financial Services Group first reported a position in PLSE in Q1 2017 and has held it in 27 quarters since. The position peaked at $242K in Q4 2023. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • PNC Financial Services Group held 5,585 shares of Pulse Biosciences worth $121K as of Q1 2026.
  • PNC Financial Services Group bought 13 Pulse Biosciences shares in Q1 2026, an estimated $240.
  • Pulse Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2685 holding.
  • PNC Financial Services Group first reported a position in Pulse Biosciences in Q1 2017 and has held it in 27 quarters since.
  • PNC Financial Services Group's Pulse Biosciences position peaked at $242K in Q4 2023.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.